Trial intelligence / Profile preview

Hyalase Hydro-dissection for Carpal Tunnel Syndrome

NCT03675295Completed

Sponsor
Assiut University
Start
Apr 2017
Primary completion
Mar 2018
Modality
Therapeutic Enzymes
Countries
1
01

Overview

Randomised, double-blind trial of hyaluronidase in carpal tunnel syndrome (CTS) (2 arms), sponsored by Assiut University. Primary endpoint: Pain alleviation at 6 months. Started Apr 2017; status: completed.

02

Drugs

hyaluronidase
03

Conditions

carpal tunnel syndrome (CTS)

Beyond the preview

Go deeper on NCT03675295.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03675295.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call